NACO

PL:NACOMI

Nacomi

  • Privately Held

Company Overview

Metric
Company NameNacomiFarmona Laboratorium Kosmetyków NaturalnychEcolab Inc.
SymbolECL
MSH IDPL:NACOMIPL:FARMONACOM:ECOLAB
MarketPRIVATEPRIVATESTOCKS
SectorConsumer GoodsConsumer GoodsBasic Materials
IndustryCosmeticsCosmeticsChemicals - Specialty
CountryPLPLUS
Stage
Employee Count48K
Websitenacomi.plfarmona.plecolab.com
LinkedInnacomi-grouplaboratorium-kosmetyk%C3%B3w-naturalnych-farmona-sp.-z-o.o.
Founders

Market Metrics

Metric
Market Cap69.47B
Enterprise Value
Monthly Web Traffic3
Web Traffic Growth
Valuation
Raised Capital

Financial Performance

Metric
Revenue15.32B
Revenue (LTM)
Revenue (NTM)
Gross Profit6.18B
EBITDA3.08B
Operating Income2.16B
Net Income1.37B
EPS4.82
Diluted EPS4.79
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.43
Operating Profit Margin0.15
EBITDA Margin0.20
Net Profit Margin0.11
Return on Equity0.21
Return on Assets0.08
Return on Capital Employed0.14

Valuation Multiples

Metric
P/E Ratio45.46
P/B Ratio7.18
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio4.76
EV Multiple27.20

Operational Metrics

Metric
Days Sales Outstanding68.46
Days Payables Outstanding59.95
Days Inventory Outstanding63.01
Operating Cycle132.61
Cash Conversion Cycle69.22
Asset Turnover0.73

Cash Flow Metrics

Metric
Operating Cash Flow2.41B
Free Cash Flow1.64B
Cash Flow to Debt0.38
Operating Cash Flow/Sales0.19
Free Cash Flow Yield0.03

Balance Sheet Metrics

Metric
Cash & Equivalents919.50M
Accounts Receivable-84.30M
Inventory1.50B
Goodwill8.15B
Debt to Capitalization0.51
Debt to Assets0.41
Current Ratio1.26
Quick Ratio1.10

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue0.01
R&D to Revenue
SG&A to Revenue